Disseminated BCG disease associated with immunotherapy by scarification in acute leukemia

P. S. Ritch, K. B. McCredie, J. U. Gutterman, Evan M Hersh

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Disseminated BCG infection developed in a patient with acute leukemia receiving BCG immunotherapy by scarification. Predisposing factors included the underlying malignancy, intensive chemotherapy, and continuous high-dose corticosteroids. The scarification technique is safe; however, physicians should be alert to this syndrome as a cause of fever of unknown origin in cancer patients receiving BCG immunotherapy.

Original languageEnglish (US)
Pages (from-to)167-170
Number of pages4
JournalCancer
Volume42
Issue number1
StatePublished - 1978
Externally publishedYes

Fingerprint

Mycobacterium bovis
Immunotherapy
Leukemia
Fever of Unknown Origin
Causality
Neoplasms
Adrenal Cortex Hormones
Physicians
Drug Therapy
Infection

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ritch, P. S., McCredie, K. B., Gutterman, J. U., & Hersh, E. M. (1978). Disseminated BCG disease associated with immunotherapy by scarification in acute leukemia. Cancer, 42(1), 167-170.

Disseminated BCG disease associated with immunotherapy by scarification in acute leukemia. / Ritch, P. S.; McCredie, K. B.; Gutterman, J. U.; Hersh, Evan M.

In: Cancer, Vol. 42, No. 1, 1978, p. 167-170.

Research output: Contribution to journalArticle

Ritch, PS, McCredie, KB, Gutterman, JU & Hersh, EM 1978, 'Disseminated BCG disease associated with immunotherapy by scarification in acute leukemia', Cancer, vol. 42, no. 1, pp. 167-170.
Ritch, P. S. ; McCredie, K. B. ; Gutterman, J. U. ; Hersh, Evan M. / Disseminated BCG disease associated with immunotherapy by scarification in acute leukemia. In: Cancer. 1978 ; Vol. 42, No. 1. pp. 167-170.
@article{ef7b85cf20124f1c933f6feaf01be34a,
title = "Disseminated BCG disease associated with immunotherapy by scarification in acute leukemia",
abstract = "Disseminated BCG infection developed in a patient with acute leukemia receiving BCG immunotherapy by scarification. Predisposing factors included the underlying malignancy, intensive chemotherapy, and continuous high-dose corticosteroids. The scarification technique is safe; however, physicians should be alert to this syndrome as a cause of fever of unknown origin in cancer patients receiving BCG immunotherapy.",
author = "Ritch, {P. S.} and McCredie, {K. B.} and Gutterman, {J. U.} and Hersh, {Evan M}",
year = "1978",
language = "English (US)",
volume = "42",
pages = "167--170",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Disseminated BCG disease associated with immunotherapy by scarification in acute leukemia

AU - Ritch, P. S.

AU - McCredie, K. B.

AU - Gutterman, J. U.

AU - Hersh, Evan M

PY - 1978

Y1 - 1978

N2 - Disseminated BCG infection developed in a patient with acute leukemia receiving BCG immunotherapy by scarification. Predisposing factors included the underlying malignancy, intensive chemotherapy, and continuous high-dose corticosteroids. The scarification technique is safe; however, physicians should be alert to this syndrome as a cause of fever of unknown origin in cancer patients receiving BCG immunotherapy.

AB - Disseminated BCG infection developed in a patient with acute leukemia receiving BCG immunotherapy by scarification. Predisposing factors included the underlying malignancy, intensive chemotherapy, and continuous high-dose corticosteroids. The scarification technique is safe; however, physicians should be alert to this syndrome as a cause of fever of unknown origin in cancer patients receiving BCG immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0018173751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018173751&partnerID=8YFLogxK

M3 - Article

C2 - 276413

AN - SCOPUS:0018173751

VL - 42

SP - 167

EP - 170

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 1

ER -